limiting the use of OTC cough and cold medicines in young children

New evidence verifies the benefit of limiting the use of OTC cough and cold medicines in young children.

The infant versions are no longer marketed...and the remaining children's products are no longer labelled for children under age 6.

Now a new report suggests this is making a big difference.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote